Intrauterine Instillation of Tranexamic Acid in Hysteroscopic Myomectomy

Phase 3

Recruiting

• Conditions: Submucous leiomyoma of uterus.; Submucous leiomyoma of uterus; D25.0

• Registration Number: IRCT20110530006640N8
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

Patients with one submucosal myoma
Myoma should be completely in the endometrial cavity or extending less than 50% into the myometrium (type 0 and 1, based on FIGO's classification)
Myoma size less than 4 cm in the largest diameter confirmed by accurate transvaginal ultrasound
Candidates for hysteroscopy and myomectomy

Exclusion Criteria

Pelvic infections
History of uterine or cervical cancer; Hematological, cardiovascular, thromboembolic, hepatic, and renal disorders; or Thromboembolic events
Taking anticoagulant agents
Uterine septum, or uterine disorders

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin Level. Timepoint: Once before surgery and once 24 hours after surgery. Method of measurement: Blood Test.